Sitagliptin Phosphate/Metformin HCl (JANUMET) Post Marketing Surveillance Protocol.
Phase of Trial: Phase IV
Latest Information Update: 11 Sep 2013
At a glance
- Drugs Metformin/sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck & Co
- 06 Mar 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 23 May 2011 New trial record